Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Mass Screening × Clear all

Phase

Phase NA 26 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Heart Diseases 1

Interventions

Cisplatin 1028 Cyclophosphamide 968 Carboplatin 947 Radiotherapy 881 Bevacizumab 840 Gemcitabine 812 pembrolizumab 756 Paclitaxel 736 Docetaxel 732 Oxaliplatin 697 Capecitabine 640 Fluorouracil 561 Rituximab 557 Nivolumab 502 Dexamethasone 486 Etoposide 464 Doxorubicin 457 Irinotecan 442 Drug Therapy 393 Leucovorin 373 Cytarabine 341 Cetuximab 338 Lenalidomide 325 Trastuzumab 319 Pemetrexed 314 durvalumab 294 Filgrastim 287 Temozolomide 276 Prednisone 273 Methotrexate 270

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01714271 2023-10-02

Promotora-based Latino Family CVD Risk Reduction

University of California, Los Angeles

Phase 2 Completed

Heart Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡